Shares of drug maker Synergy Pharmaceuticals Inc (NASDAQ:SGYP) rose nearly 9% today after the FDA has accepted the company’s plecanatide for review, allowing investors to breathe a …
International Business Machines Corp. (NYSE:IBM) is down over 5% in pre-market trading after the company posted its Q1:16 revenues yesterday after market close.
Healthcare analysts from Mizuho and Rodman and Renshow explain their views on recent announcements made by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy …
While Canadian drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced the return of Mike Pearson as CEO, biopharma firm Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported its …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results …
Analyst Raghuram Selvaraju of Rodman & Renshaw is bullish on both Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP), though for …
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company pioneering the development of uroguanylin analogs as potential new treatments for functional gastrointestinal (GI) disorders and …
Healthcare analysts weigh in today on biotech companies Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Mast Therapeutics Inc (NYSEMKT:MSTX). The analysts positively viewed SGYP’s Plecanatide NDA submission, …
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the company has filed with the U.S.
Healthcare analysts are out with commentary on biotech stocks Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
